Old; Lloyd J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Old; Lloyd J..The latest application filed is for "methods of treating neoplastic astrocytoma".

Company Profile

3.84.53

Old; Lloyd J. - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Treating Neoplastic Astrocytoma App 20210032366 - Old; Lloyd J. ; et al.	2021-02-04
Antibodies directed to membrane transporter NaP12b (SLC34A2) and uses thereof in cancer therapy Grant 10,385,138 - Ritter , et al. A	2019-08-20
Methods Of Treating Meningioma App 20180057606 - Old; Lloyd J. ; et al.	2018-03-01
Membrane Transporter NaPi2b (SCL34A2) Epitope for Antibody Therapy, Antibodies Directed Thereto, and Target for Cancer Therapy App 20170362336 - Ritter; Gerd ; et al.	2017-12-21
Membrane transporter NaPi2b (SCL34A2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy Grant 9,701,755 - Ritter , et al. July 11, 2	2017-07-11
Specific binding proteins and uses thereof Grant 9,562,102 - Old , et al. February 7, 2	2017-02-07
Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof Grant 9,283,276 - Johns , et al. March 15, 2	2016-03-15
Specific Binding Proteins And Uses Thereof App 20160046726 - Old; Lloyd J. ; et al.	2016-02-18
Membrane Transporter NaPi2b (SCL34A2) Epitope for Antibody Therapy, Antibodies Directed Thereto, and Target for Cancer Therapy App 20160009816 - Ritter; Gerd ; et al.	2016-01-14
Membrane transporter NaPi2b (SCL34A2) epitope antibodies Grant 9,045,533 - Ritter , et al. June 2, 2	2015-06-02
Immunogenic Compositions Useful In Provoking An Integrated Response To Tumor Antigens App 20140255436 - TSUJI; Takemasa ; et al.	2014-09-11
Specific binding proteins and uses thereof App 20140255410 - Old; Lloyd J. ; et al.	2014-09-11
Membrane Transporter NaPi2b (SCL34A2) Epitope for Antibody Therapy, Antibodies Directed Thereto, and Target for Cancer Therapy App 20140193417 - Ritter; Gerd ; et al.	2014-07-10
Antibodies to EGF receptor epitope peptides and uses thereof Grant 8,652,473 - Johns , et al. February 18, 2	2014-02-18
Specific binding proteins and uses thereof App 20130266573 - Old; Lloyd J. ; et al.	2013-10-10
Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein Grant 8,541,202 - Knuth , et al. September 24, 2	2013-09-24
Methods for stimulating an immune response using bacterial antigen delivery system Grant 8,357,373 - Old , et al. January 22, 2	2013-01-22
Immunogenic Compositions Useful In Provoking An Integrated Response To Tumor Antigens App 20120328660 - TSUJI; Takemasa ; et al.	2012-12-27
Seromic Analysis Of Ovarian Cancer App 20120283115 - Ritter; Gerd ; et al.	2012-11-08
Method For Inducing Cell Lysis With Immunogenic Portions Of Ny-eso-1 Protein App 20120231035 - Knuth; Alexander ; et al.	2012-09-13
Human sarcoma-associated antigens Grant 8,252,903 - Scanlan , et al. August 28, 2	2012-08-28
Specific Binding Proteins And Uses Thereof App 20120183471 - Old; Lloyd J. ; et al.	2012-07-19
Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein Grant 8,142,786 - Knuth , et al. March 27, 2	2012-03-27
Specific Binding Proteins And Uses Thereof App 20110313230 - Johns; Terrance Grant ; et al.	2011-12-22
Specific Binding Proteins And Uses Thereof App 20110293511 - Johns; Terrance Grant ; et al.	2011-12-01
Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein App 20110182944 - Knuth; Alexander ; et al.	2011-07-28
Cancer-testis antigens App 20110177079 - Chen; Yao-Tseng ; et al.	2011-07-21
Colon Cancer Associated Transcript 1 (CCAT1) As A Cancer Marker App 20110097271 - Nissan; Aviram ; et al.	2011-04-28
Specific Binding Proteins And Uses Thereof App 20110076232 - Old; Lloyd J. ; et al.	2011-03-31
Isolated nucleic acid molecules which encode immunogenic portions of NY-ESO-1 protein Grant 7,888,100 - Knuth , et al. February 15, 2	2011-02-15
EGF receptor epitope peptides and uses thereof App 20100322937 - Johns; Terrance Grant ; et al.	2010-12-23
Method for inducing immune response to NY-CO-58 Grant 7,803,382 - Old , et al. September 28, 2	2010-09-28
Antibodies to EGF receptor epitope peptides Grant 7,767,792 - Johns , et al. August 3, 2	2010-08-03
Human Sarcoma-associated Antigens App 20100172910 - Scanlan; Matthew J. ; et al.	2010-07-08
Specific Binding Proteins And Uses Thereof App 20100056762 - Old; Lloyd J.	2010-03-04
Human sarcoma-associated antigens Grant 7,662,917 - Scanlan , et al. February 16, 2	2010-02-16
Methods for Stimulating an Immune Response Using Bacterial Antigen Delivery System App 20090324651 - Old; Lloyd J. ; et al.	2009-12-31
Specific binding proteins and uses thereof Grant 7,589,180 - Old , et al. September 15, 2	2009-09-15
Specific binding proteins and uses thereof App 20090220510 - Old; Lloyd J. ; et al.	2009-09-03
Human sarcoma-associated antigens Grant 7,560,537 - Scanlan , et al. July 14, 2	2009-07-14
Induction Of Regulatory T Cell-resistant Helper Cd4+ T Cells App 20090136446 - NISHIKAWA; HIROYOSHI ; et al.	2009-05-28
Specific Binding Proteins And Uses Thereof App 20090137782 - Old; Lloyd J. ; et al.	2009-05-28
Colon cancer antigen panel App 20080226664 - Old; Lloyd J. ; et al.	2008-09-18
Isolated Ny-Eso-1 Peptides Which Bind To Hla Class II Molecules And Uses Thereof App 20080139464 - Gnjatic; Sacha ; et al.	2008-06-12
Human Sarcoma-Associated Antigens App 20080089888 - Scanlan; Matthew J. ; et al.	2008-04-17
Breast cancer antigens Grant 7,335,467 - Scanlan , et al. February 26, 2	2008-02-26
Small cell lung cancer associated antigens and uses therefor Grant 7,314,721 - Gure , et al. January 1, 2	2008-01-01
Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof Grant 7,291,335 - Stockert , et al. November 6, 2	2007-11-06
Method for generating an immune response and reagents therefor Grant 7,259,235 - Old , et al. August 21, 2	2007-08-21
Isolated peptides corresponding to amino acid requirements of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof App 20060269960 - Knuth; Alexander ; et al.	2006-11-30
Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53 Grant 7,115,729 - Knuth , et al. October 3, 2	2006-10-03
Method for generating an immune response and reagents therefor App 20060204507 - Old; Lloyd J. ; et al.	2006-09-14
Cancer-testis antigens App 20060089303 - Old; Lloyd J. ; et al.	2006-04-27
Isolated peptides which bind to HLA-C molecules and uses thereof Grant 7,009,035 - Gnjatic , et al. March 7, 2	2006-03-07
Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer Grant 6,982,316 - Scanlan , et al. January 3, 2	2006-01-03
EGF receptor epitope peptides and uses thereof App 20050255555 - Johns, Terrance Grant ; et al.	2005-11-17
Isolated proteins containing portions of FAP.alpha. and other proteins Grant 6,846,910 - Zimmermann , et al. January 25, 2	2005-01-25
Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof Grant 6,830,924 - Chen , et al. December 14, 2	2004-12-14
Cancer-testis antigens App 20040235066 - Old, Lloyd J. ; et al.	2004-11-25
Colon cancer antigen panel Grant 6,794,501 - Chen , et al. September 21, 2	2004-09-21
Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53 App 20040158044 - Knuth, Alexander ; et al.	2004-08-12
Small cell lung cancer associated antigens and uses therefor App 20040126808 - Gure, Ali O. ; et al.	2004-07-01
Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof Grant 6,723,832 - Knuth , et al. April 20, 2	2004-04-20
Human sarcoma-associated antigens App 20040063101 - Scanlan, Matthew J. ; et al.	2004-04-01
Cancer associated antigens and uses therefor Grant 6,686,147 - Scanlan , et al. February 3, 2	2004-02-03
Method for treating cancer using A33 specific antibodies and chemotherapeutic agents Grant 6,652,853 - Welt , et al. November 25, 2	2003-11-25
Cancer-testis antigens App 20030180298 - Old, Lloyd J. ; et al.	2003-09-25
Isolated peptides which bind to HLA molecules and uses thereof App 20030175250 - Jager, Elke ; et al.	2003-09-18
Colon cancer antigen panel App 20030165834 - Chen, Yao-Tseng ; et al.	2003-09-04
Breast cancer antigens App 20030108888 - Scanlan, Matthew J. ; et al.	2003-06-12
Isolated peptides which bind to HLA-C molecules and uses thereof App 20030050451 - Gnjatic, Sacha ; et al.	2003-03-13
Cancer-testis antigens App 20030044813 - Old, Lloyd J. ; et al.	2003-03-06
Truncated forms of NY-ESO-1 protein Grant 6,525,177 - Stockert , et al. February 25, 2	2003-02-25
Methods of treating colon cancer utilizing tumor-specific antibodies App 20030031671 - Welt, Sydney ; et al.	2003-02-13
Recombinant human anti-Lewis Y antibodies Grant 6,518,415 - Armour , et al. February 11, 2	2003-02-11
Antibodies specific for SSX proteins App 20030023057 - Gure, Ali O. ; et al.	2003-01-30
Method for treating cancer using A33 specific antibodies and chemotherapeutic agents App 20020187144 - Welt, Sydney ; et al.	2002-12-12
Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof App 20020164665 - Stockert, Elisabeth ; et al.	2002-11-07
Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof App 20020111470 - Chen, Yao-Tseng ; et al.	2002-08-15
Isolated nucleic acid molecules associated with colon, renal, and stomach cancer and methods of using these Grant 6,403,373 - Scanlan , et al. June 11, 2	2002-06-11
Method for treating cancers which present antigen FB5 with humanized antibodies Grant 6,391,302 - Wallace , et al. May 21, 2	2002-05-21
Isolated Proteins Containing Portions Of Fapalpha And Other Proteins App 20020034789 - ZIMMERMANN, RAINER ; et al.	2002-03-21
Compositions containing a p53 derived protein or peptide, an adjuvant, and interleukin-12 and uses thereof Grant 6,355,256 - Noguchi , et al. March 12, 2	2002-03-12
Method for treating cancers Grant 6,348,195 - Wallace , et al. February 19, 2	2002-02-19
A33 antigen specific immunoglobulin products and uses thereof Grant 6,342,587 - Barbas, III , et al. January 29, 2	2002-01-29
Truncated forms of NY-ESO-1 protein App 20020010321 - Chen, Yao-tseng ; et al.	2002-01-24
Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith Grant 6,338,947 - Sahin , et al. January 15, 2	2002-01-15
Recombinant human anti-Lewis Y antibodies Grant 6,310,185 - Wallace , et al. October 30, 2	2001-10-30
Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof Grant 6,274,145 - Chen , et al. August 14, 2	2001-08-14
Method for determining status of a cancerous condition by determining antibodies to NY-ESO-1 in a patient sample Grant 6,251,603 - Jager , et al. June 26, 2	2001-06-26
Methods for detecting cancer cells by using humanized antibodies which bind specifically to FB5 antigen Grant 6,217,868 - Wallace , et al. April 17, 2	2001-04-17
Method for treating neoplasia using humanized antibodies which bind to antigen A33 Grant 6,190,640 - Welt , et al. February 20, 2	2001-02-20
Method for detecting cancers Grant 6,124,106 - Wallace , et al. September 26, 2	2000-09-26
Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof Grant 6,069,233 - Chen , et al. May 30, 2	2000-05-30
Process for producing GM2 specific antibodies Grant 6,057,115 - Ritter , et al. May 2, 2	2000-05-02
Isolated dimeric fibroblast activation protein .alpha., and uses thereof Grant 5,965,373 - Zimmermann , et al. October 12, 1	1999-10-12
Recombinant human anti-LK26 antibodies Grant 5,952,484 - Wallace , et al. September 14, 1	1999-09-14
Recombinant human anti-Lewis Y antibodies Grant 5,874,060 - Armour , et al. February 23, 1	1999-02-23
Recombinant humanized anti-FB5 antibodies Grant 5,811,522 - Wallace , et al. September 22, 1	1998-09-22
Methods of synthesizing GM2 Grant 5,756,695 - Schmidt , et al. May 26, 1	1998-05-26
Isolated protein which binds to A33 antibody, and peptides corresponding to portions of the protein Grant 5,712,369 - Old , et al. January 27, 1	1998-01-27
Monoclonal antibodies which bind to tumor rejection antigen precursor melan-A, and uses thereof Grant 5,674,749 - Chen , et al. October 7, 1	1997-10-07
Recombinant human anti-LK26 antibodies Grant 5,646,253 - Wallace , et al. July 8, 1	1997-07-08
Method of treating colorectal carcinoma lesion and composition for use therein Grant 5,643,550 - Welt , et al. July 1, 1	1997-07-01
Isolated sialylated glycoprotein endosialin, which is expressed by tumor associated vascular endothelium Grant 5,437,865 - Garin-Chesa , et al. August 1, 1	1995-08-01
Method of imaging colorectal carcinoma lesion and composition for use therein Grant 5,431,897 - Welt , et al. July 11, 1	1995-07-11
Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof Grant 5,342,757 - Garin-Chesa , et al. August 30, 1	1994-08-30
Method of imaging colorectal carcinoma lesion and composition for use therein Grant 5,160,723 - Welt , et al. November 3, 1	1992-11-03
Vaccine for stimulating or enhancing production of antibodies against 9-O-acetyl GD3 Grant 5,102,663 - Livingston , et al. April 7, 1	1992-04-07
Cell-surface glycoproteins of human sarcomas Grant 5,059,523 - Rettig , et al. October 22, 1	1991-10-22
Human monoclonal antibodies to cell surface antigens of melanoma Grant 5,006,470 - Yamaguchi , et al. April 9, 1	1991-04-09
Monoclonal antibodies selective for prostate cancer Grant 4,970,299 - Bazinet , et al. November 13, 1	1990-11-13
Method for characterizing types of renal carcinoma and prognosis Grant 4,935,344 - Bander , et al. June 19, 1	1990-06-19
Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor Grant 4,870,163 - Rubin , et al. September 26, 1	1989-09-26
Monoclonal antibodies to human lung cancers and method Grant 4,865,998 - Feickert , et al. September 12, 1	1989-09-12
Choriocarcinoma monoclonal antibodies and antibody panels Grant 4,851,332 - Rettig , et al. July 25, 1	1989-07-25
Monoclonal antibody specific for a pigmentation associated antigen Grant 4,798,790 - Thomson , et al. January 17, 1	1989-01-17
Monoclonal antibodies to cell surface antigens of human teratocarcinomas Grant 4,762,800 - Rettig , et al. August 9, 1	1988-08-09
Monoclonal antibody panel for early diagnosis and therapy of renal carcinoma Grant 4,713,352 - Bander , et al. December 15, 1	1987-12-15
Human monoclonal antibodies to cell surface antigens Grant 4,695,538 - Cote , et al. September 22, 1	1987-09-22
Human monoclonal antibodies from lymphocytes of patients with malignant melanoma Grant 4,693,966 - Houghton , et al. September 15, 1	1987-09-15
Monoclonal antibodies for detection of an H (O) blood group antigen Grant 4,678,747 - Lloyd , et al. July 7, 1	1987-07-07
Monoclonal antibodies to cell surface antigens of human renal cancer Grant 4,650,756 - Old , et al. March 17, 1	1987-03-17
Monoclonal antibodies to human bladder and ureter cancers and method Grant 4,643,971 - Fradet , et al. February 17, 1	1987-02-17
Cell surface antigens of human astrocytoma Grant 4,642,291 - Cairncross , et al. February 10, 1	1987-02-10
Human monoclonal antibodies to cancer cells Grant 4,613,576 - Cote , et al. September 23, 1	1986-09-23
Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies Grant 4,579,827 - Sakamoto , et al. April 1, 1	1986-04-01
Melanoma tumor antigen and autologous antibody Grant 4,562,160 - Real , et al. December 31, 1	1985-12-31
Method for detecting the presence of G.sub.D3 ganglioside Grant 4,507,391 - Pukel , et al. March 26, 1	1985-03-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.